Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies
2023 · Blood Cancer Journal · 72 citations
https://doi.org/10.1038/s41408-023-00822-w
J
Jia Xu
Union Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
721
Citations
15
h-index
20
i10-index
Jia Xu is an academic researcher from Union Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Analytical chemistry methods development & RNA Interference and Gene Delivery. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0000-0002-6877-3611Papers by this author
worksBispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
2023 · Leukemia · 64 citations
https://doi.org/10.1038/s41375-023-02065-x
Differential Neuronal Activation of Nociceptive Pathways in Neuropathic Pain After Spinal Cord Injury
2025 · Cellular and Molecular Neurobiology · 6 citations
https://doi.org/10.1007/s10571-025-01532-6
Deep eutectic solvent-based manganese dioxide nanosheets composites for determination of DNA by a colorimetric method
2023 · BMC Chemistry · 2 citations
https://doi.org/10.1186/s13065-023-00922-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat